Lucentis (ranibizumab) - Important Safety Information as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 23/02/2011

Problem Or Issue:
Important Safety Information communciation from Novartis regarding presence of blocked needles in some Lucentis injection administration packs

Important Safety Information - Lucentis 10mg/ml solution for injection

« Back